anti-ATP-Binding Cassette, Sub-Family B (MDR/TAP), Member 1B (ABCB1B) Anticorps

Human ATP-Binding Cassette, Sub-Family B (MDR/TAP), Member 1B (ABCB1B) interaction partners

1. analysis of seven polymorphisms in genes of folate transport and (de)glutamation pathway on methotrexate polyglutamate levels and response in patients with rheumatoid arthritis: ABCB1, FPGS, GGH and RFC1

2. the results suggest a possible genetic contribution of single-nucleotide polymorphisms within the ABCB1 and COMT genes in individuals with higher levels of pain sensitivity

3. ABCB1 genetic polymorphisms affect aripiprazole-related autonomic nervous system dysfunction in patients treated for schizophrenia.

4. RPN2 potentiated P-gp- and ABCG2-mediated MDR via activating MEK/ERK pathway in GC

5. MDR-1 genetic variants were not associated with treatment resistance when compared to responders to clopidogrel therapy.

6. BEL repressed rifampicin-induced gene expression of CYP3A4 and multidrug resistance protein 1, as well as their respective protein activities.

7. Patients with low OCT-1 activity and high ABCB1 fold rise have poor long-term outcomes.

8. The data presented herein demonstrate that the P-glycoprotein mRNA transcript is regulated by cooperation between miR-19b and the RNA-binding protein HuR

9. High ABCB1 expression is associated with vinorelbine resistance in lung cancer.

10. The studied polymorphism in ABCB1 does not seem to affect the increased risk of multiple myeloma development.

11. Dual luciferase activity assay demonstrated that ZNF139 inhibited transcriptional activities of miR-185's promoter in cells transfected with the reporter plasmid encompassing the upstream promoter region of miR-185 along with pcDNA-ZNF139. Our data reveal that ZNF139 might promote MDR gene MDR1/P-gp, MRP-1 and Bcl-2 by prohibiting miR-185

12. The ABCB1 (C1236T) polymorphism affects P-gp-mediated transport of osteosarcoma drugs in a drug-specific way

13. MDR1 overexpression enhanced the viability and doxorubicin resistance of colon cancer cells.

14. The carriage of ABCB1 mutant allele was not significantly associated with clopidogrel resistance risk.

15. Genotyping of ABCB1 variants can help to prevent severe adverse reactions to irinotecan-based treatments in colorectal cancer.

16. Our results suggested that the in vitro efficacy of anticancer drugs on the proliferation of colon cancer cells was significantly affected by P-gp in cancer cell lines abundantly expressing P-gp, accounting for 1.5% of cancer cell lines of all cancer types and 14.5% of colon cancer cell lines in the Cancer Cell Line Encyclopedia.

17. Pgp expression was associated with an increase in the proinflammatory nature of CD8+ cells in bronchiolitis obliterans syndrome

18. Genotype distribution was in Hardy-Weinberg equilibrium for all three ABCB1polymorphisms. For c.1236C>T and c.3435C>T, the heterozygous C/T was the most frequent genotype, while heterozygous G/T was the most common genotype for c.2677G>T/A, mainly followed by G/G and T/T. 12 haplotypes were estimated from the three ABCB1 polymorphisms analyzed, with TTT the most frequent haplotype.

19. This study aimed to explore the connection between the 10-hydroxycarbazepine concentration and genes such as ATP-binding cassette B1 (ABCB1), ATP-binding cassette C2 (ABCC2), UDP-glucuronosyltransferase-2B7 and sodium voltage-gated channel alpha subunit 2 (SCN2A), which participate in the antiepileptic function of oxcarbazepine

20. Study identified that the miRNA149 contributes to the development of multidrug resistance within malignant mesothelioma cells by regulating the expression of MDR1.

Mouse (Murine) ATP-Binding Cassette, Sub-Family B (MDR/TAP), Member 1B (ABCB1B) interaction partners

1. esults suggest that P-gp plays important role in mediating rivastigmine non-cholinergic beneficial effects, including Abeta brain load reduction, neuroprotective and anti-inflammatory effects in the AD mouse models.

2. this study shows that MDR1 deficiency impairs mitochondrial homeostasis and promotes intestinal inflammation

3. A panel of 18 P-gp substrates were administered into the airways of an isolated perfused mouse lung (IPML) model derived from Mdr1a/Mdr1b knockout mice. Parallel intestinal absorption studies were performed. Lung P-gp can affect the pulmonary kinetics of a subset of P-gp substrates.

4. Data suggest that the overexpression of P-gp in neoplastic cells may be associated with alterations in O-glycosylated cell surface proteins, including mucins, and this alteration may be responsible for the reduced cell sensitivity to the O-glycosylation inhibitor GalNAc-alpha-O-benzyl.

5. We conclude that mdr1b and bcrp are essential to ovarian protection from chemotoxicity and may have an important physiological role in the ovary.

6. Molecular Dynamics simulations and docking of drugs performed for P-gp (P-gp, multi-drug resistance protein, MDR1).Drugs with ER < 1 almost do not bind the main binding cavity (MBC) of P-gp.

7. conclusion, MDR1 and BCRP are expressed on apical membranes of the rodent placental SynT-II layer.

8. Mdr1 enforces T Cell homeostasis in the presence of intestinal bile acids.

9. Loss of ABCB1 expression is associated with neonatal hyperbilirubinemia.

10. the high-affinity site of P-glycoprotein is inaccessible because of either a conformational change or binding of detergent at the binding site in a detergent micelle environment; ligands bind to a low-affinity site, resulting in altered modulation of P-gp ATPase activity

11. Data suggest that ATP binding to Abcb1b/P-glycoprotein (Pgp) in liposomes exhibits cooperativity with verapamil (a cardiovascular/antiarrhythmia drug); cooperativity between verapamil and a nonhydrolyzable ATP analog (AMPPNP) leads to distinct global conformational changes in Abcb1b/Pgp.

12. Chrysosplenetin inhibited P-gp activity and reverse the up-regulated P-gp and MDR1 levels induced by artemisinin.

13. Tamsulosin and tolterodine with P-gp gene expression and activity in an enantiomer-specific way.

14. Pgp-coupled ATPase activity kinetics measured with a range of verapamil and digoxin concentrations fit well to a DDI model encompassing non-competitive and competitive inhibition of digoxin by verapamil.

15. Data show that human transgenic mutant huntingtin (mHtt) aggregation might be regulated by multidrug resistance protein 1 (MDR1) which suggests that MDR1 might be a potential therapeutic target for Huntington's disease.

16. In vitro and in vivo downregulation of the ATP binding cassette transporter B1 by the HMG-CoA reductase inhibitor simvastatin

17. Efficient chemoprotection of CDD and MDR1 transduced hematopoietic 32D as well as primary lin(-) cells was proven in the context of Ara-C and anthracycline application

18. Mdr1b participates in the elimination of paraquat from the kidneys and protects against subsequent toxicity.

19. These study data have facilitated understanding of the molecular mechanisms of neurotoxicosis in ABCB1-1Delta mutant mice following exposure to various P-gp substrates.

20. Data indicate that the brain penetration of ABT-888 in both Abcb1a/1b-/- and Abcb1a/1b-/-;Abcg2-/- mice was significantly higher than in wild-type mice.